The 10th LSX World Congress is the leading partnering, strategy and investment event in Europe, with qualified 1:1 partnering at its core.

The event brings together the CEOs and senior decision makers from the world’s most innovative biopharma, medtech and healthtech companies with investors, senior BD&L teams, R&D leaders and industry KOLs. Together, they share best practice, forge partnerships and investments – all geared at putting capital and ideas to work to help create the world’s future medicines and improve patient outcomes.

The event runs for two days, 29 – 30 April 2024

Anne Horgan, Partner at Cambridge Innovation Capital will join the event on Day 1.

Please register to attend here and find the full agenda at the link below.